Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qin Song

Showing results (381-390 of 390) with videos related to

Pageof 39
Sort By:
You have reached the last page of results.This site can display upto 390 results.
Blood Advances|July 14, 2020
First-line non-anthracycline-based chemotherapy for extranodal nasal-type NK/T-cell lymphoma: a retrospective analysis from the CLCGShu-Nan Qi, Yong Yang, Yu-Qin Song, et al.
Haematologica|March 23, 2023
Evidence of cure for extranodal nasal-type natural killer/T-cell lymphoma with current treatment: an analysis of the CLCG databaseXin Liu, Li-Ling Zhang, Bao-Lin Qu, et al.
International Journal of Radiation Oncology, Biology, Physics|September 19, 2025
Survival Benefit of Adjuvant Radiation Therapy Following Asparaginase-Based Chemotherapy in Patients With Chemoresponsive Advanced-Stage Extranodal NK/T Cell Lymphoma: A Multicenter Study Using the China Lymphoma Collaborative Group DatabaseKe Su, Xiao-Rong Hou, Qiu-Zi Zhong, et al.
Therapeutic Advances in Medical Oncology|October 14, 2024
Optimizing the combination of chemotherapeutic drugs along with radiotherapy for extranodal NK/T-cell lymphomaFei Luo, Qiu-Zi Zhong, Xin Liu, et al.
Blood Advances|April 20, 2023
Orelabrutinib for the treatment of relapsed or refractory MCL: a phase 1/2, open-label, multicenter, single-arm studyLi-Juan Deng, Ke-Shu Zhou, Li-Hong Liu, et al.
Arthritis Research & Therapy|May 14, 2024
Unraveling transcriptomic signatures and dysregulated pathways in systemic lupus erythematosus across disease statesFrank Qingyun Wang, Li Shao, Xiao Dang, et al.
Annals of Hematology|June 12, 2023
Outcome and risk prediction of early progression in patients with extranodal natural killer/T cell lymphoma from the CLCG studyJia-Ying Li, Xiao-Rong Hou, Si-Ye Chen, et al.
Leukemia|March 11, 2020
Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision-makingSi-Ye Chen, Yong Yang, Shu-Nan Qi, et al.
Nature Communications|February 4, 2021
Identification of 38 novel loci for systemic lupus erythematosus and genetic heterogeneity between ancestral groupsYong-Fei Wang, Yan Zhang, Zhiming Lin, et al.
JAMA|April 22, 2026
Tucidinostat Plus R-CHOP vs R-CHOP in MYC/BCL2 Double-Expressor Diffuse Large B-Cell Lymphoma: A Randomized Clinical TrialPeng-Peng Xu, Yu-Qin Song, Jian-Zhen Shen, et al.
Pageof 39

Showing results (381-390 of 390) with videos related to

Sort By:
Pageof 39
You have reached the last page of results.This site can display upto 390 results.
Blood Advances|July 14, 2020
First-line non-anthracycline-based chemotherapy for extranodal nasal-type NK/T-cell lymphoma: a retrospective analysis from the CLCGShu-Nan Qi, Yong Yang, Yu-Qin Song, et al.
Haematologica|March 23, 2023
Evidence of cure for extranodal nasal-type natural killer/T-cell lymphoma with current treatment: an analysis of the CLCG databaseXin Liu, Li-Ling Zhang, Bao-Lin Qu, et al.
International Journal of Radiation Oncology, Biology, Physics|September 19, 2025
Survival Benefit of Adjuvant Radiation Therapy Following Asparaginase-Based Chemotherapy in Patients With Chemoresponsive Advanced-Stage Extranodal NK/T Cell Lymphoma: A Multicenter Study Using the China Lymphoma Collaborative Group DatabaseKe Su, Xiao-Rong Hou, Qiu-Zi Zhong, et al.
Therapeutic Advances in Medical Oncology|October 14, 2024
Optimizing the combination of chemotherapeutic drugs along with radiotherapy for extranodal NK/T-cell lymphomaFei Luo, Qiu-Zi Zhong, Xin Liu, et al.
Blood Advances|April 20, 2023
Orelabrutinib for the treatment of relapsed or refractory MCL: a phase 1/2, open-label, multicenter, single-arm studyLi-Juan Deng, Ke-Shu Zhou, Li-Hong Liu, et al.
Arthritis Research & Therapy|May 14, 2024
Unraveling transcriptomic signatures and dysregulated pathways in systemic lupus erythematosus across disease statesFrank Qingyun Wang, Li Shao, Xiao Dang, et al.
Annals of Hematology|June 12, 2023
Outcome and risk prediction of early progression in patients with extranodal natural killer/T cell lymphoma from the CLCG studyJia-Ying Li, Xiao-Rong Hou, Si-Ye Chen, et al.
Leukemia|March 11, 2020
Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision-makingSi-Ye Chen, Yong Yang, Shu-Nan Qi, et al.
Nature Communications|February 4, 2021
Identification of 38 novel loci for systemic lupus erythematosus and genetic heterogeneity between ancestral groupsYong-Fei Wang, Yan Zhang, Zhiming Lin, et al.
JAMA|April 22, 2026
Tucidinostat Plus R-CHOP vs R-CHOP in MYC/BCL2 Double-Expressor Diffuse Large B-Cell Lymphoma: A Randomized Clinical TrialPeng-Peng Xu, Yu-Qin Song, Jian-Zhen Shen, et al.
Pageof 39